Byrne Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Byrne Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$32.6K	Buy
2025 Q2	–	Sell
2025 Q1	$29.9K	Buy
2023 Q3	–	Sell
2023 Q2	$5K	Buy